← Back to signals
CRL
N/ACharles River Laboratories Intl.
Health Care
—
PEGY ratio
Why This Matters
Strong projected growth of 436.8% annually over 5 years.
EPS is negative — company is currently unprofitable. PEGY not meaningful.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
Scan date: 2026-05-08
Valuation
—
P/E Ratio
Growth
436.8%
5yr EPS
Income
0.0%
Div Yield
PEGY Components
PEGY Score—
Denominator436.8%
EPS (TTM)$-3.71
Market Data
Price$181.68
ExchangeNYSE
S&P 500
What Changed
No significant changes vs 7 days ago.
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only